Cargando…
Truly continuous low pH viral inactivation for biopharmaceutical process integration
Continuous virus inactivation (VI) has received little attention in the efforts to realize fully continuous biomanufacturing in the future. Implementation of continuous VI must assure a specific minimum incubation time, typically 60 min. To guarantee the minimum incubation time, we implemented a pac...
Autores principales: | Martins, Duarte L., Sencar, Jure, Hammerschmidt, Nikolaus, Flicker, Andreas, Kindermann, Johanna, Kreil, Thomas R., Jungbauer, Alois |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187162/ https://www.ncbi.nlm.nih.gov/pubmed/32017010 http://dx.doi.org/10.1002/bit.27292 |
Ejemplares similares
-
Editorial: Antibodies and other biopharmaceuticals
por: Jungbauer, Alois
Publicado: (2008) -
Detergent-Mediated Virus Inactivation in Biotechnological Matrices: More than Just CMC
por: Farcet, Jean-Baptiste, et al.
Publicado: (2023) -
Continuous cell flocculation for recombinant antibody harvesting
por: Burgstaller, Daniel, et al.
Publicado: (2017) -
Developments and opportunities in continuous biopharmaceutical manufacturing
por: Khanal, Ohnmar, et al.
Publicado: (2021) -
Synthesis of “Nereid,” a new phenol‐free detergent to replace Triton X‐100 in virus inactivation
por: Farcet, Jean‐Baptiste, et al.
Publicado: (2020)